$48.37
0.39% yesterday
Nasdaq, Oct 01, 10:00 pm CET
ISIN
US4158581094
Symbol
HROW

Harrow Health, Inc. Target price 2025 - Analyst rating & recommendation

Harrow Health, Inc. Classifications & Recommendation:

Buy
93%
Hold
7%

Harrow Health, Inc. Price Target

Target Price $64.26
Price $48.37
Potential
Number of Estimates 9
9 Analysts have issued a price target Harrow Health, Inc. 2026 . The average Harrow Health, Inc. target price is $64.26. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 13 Analysts recommend Harrow Health, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Harrow Health, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Harrow Health, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 199.61 287.02
53.32% 43.79%
EBITDA Margin 11.83% 25.65%
17.10% 116.86%
Net Margin -8.76% 4.97%
53.29% 156.75%

10 Analysts have issued a sales forecast Harrow Health, Inc. 2025 . The average Harrow Health, Inc. sales estimate is

$287m
Unlock
. This is
26.07% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$303m 33.26%
Unlock
, the lowest is
$271m 19.15%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $200m 53.32%
2025
$287m 43.79%
Unlock
2026
$406m 41.32%
Unlock
2027
$533m 31.31%
Unlock
2028
$670m 25.79%
Unlock
2029
$789m 17.79%
Unlock
2030
$906m 14.78%
Unlock
2031
$1.1b 17.02%
Unlock
2032
$1.2b 16.79%
Unlock

7 Analysts have issued an Harrow Health, Inc. EBITDA forecast 2025. The average Harrow Health, Inc. EBITDA estimate is

$73.6m
Unlock
. This is
127.41% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$84.8m 162.09%
Unlock
, the lowest is
$61.0m 88.48%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $23.6m 79.54%
2025
$73.6m 211.79%
Unlock
2026
$141m 91.65%
Unlock
2027
$201m 42.47%
Unlock
2028
$289m 43.59%
Unlock
2029
$345m 19.62%
Unlock
2030
$375m 8.70%
Unlock
2031
$395m 5.28%
Unlock
2032
$415m 5.09%
Unlock

EBITDA Margin

2024 11.83% 17.10%
2025
25.65% 116.86%
Unlock
2026
34.78% 35.59%
Unlock
2027
37.74% 8.51%
Unlock

10 Harrow Health, Inc. Analysts have issued a net profit forecast 2025. The average Harrow Health, Inc. net profit estimate is

$14.3m
Unlock
. This is
239.59% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$32.4m 416.52%
Unlock
, the lowest is
$360k 103.52%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-17.5m 28.39%
2025
$14.3m 181.69%
Unlock
2026
$68.3m 378.57%
Unlock
2027
$114m 66.78%
Unlock

Net Margin

2024 -8.76% 53.29%
2025
4.97% 156.75%
Unlock
2026
16.85% 239.03%
Unlock
2027
21.40% 27.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.49 0.39
34.67% 179.59%
P/E 124.38
EV/Sales 6.83

10 Analysts have issued a Harrow Health, Inc. forecast for earnings per share. The average Harrow Health, Inc. EPS is

$0.39
Unlock
. This is
250.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.88 438.46%
Unlock
, the lowest is
$0.01 103.85%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.49 34.67%
2025
$0.39 179.59%
Unlock
2026
$1.86 376.92%
Unlock
2027
$3.10 66.67%
Unlock
2028
$5.07 63.55%
Unlock
2029
$5.93 16.96%
Unlock
2030
$6.35 7.08%
Unlock

P/E ratio

Current -186.04 301.04%
2025
124.38 166.86%
Unlock
2026
25.98 79.11%
Unlock
2027
15.58 40.03%
Unlock

Based on analysts' sales estimates for 2025, the Harrow Health, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.60 20.96%
2025
6.83 20.64%
Unlock
2026
4.83 29.24%
Unlock
2027
3.68 23.84%
Unlock
2028
2.92 20.51%
Unlock
2029
2.48 15.11%
Unlock
2030
2.16 12.88%
Unlock
2031
1.85 14.54%
Unlock
2032
1.58 14.38%
Unlock

P/S ratio

Current 7.86 22.50%
2025
6.24 20.68%
Unlock
2026
4.41 29.24%
Unlock
2027
3.36 23.84%
Unlock
2028
2.67 20.51%
Unlock
2029
2.27 15.10%
Unlock
2030
1.98 12.88%
Unlock
2031
1.69 14.54%
Unlock
2032
1.45 14.38%
Unlock

Current Harrow Health, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Lake Street
Locked
Locked
Locked Sep 29 2025
HC Wainwright & Co.
Locked
Locked
Locked Sep 29 2025
BTIG
Locked
Locked
Locked Sep 29 2025
BTIG
Locked
Locked
Locked Sep 24 2025
BTIG
Locked
Locked
Locked Sep 23 2025
Craig-Hallum
Locked
Locked
Locked Sep 23 2025
B. Riley Securities
Locked
Locked
Locked Sep 23 2025
Analyst Rating Date
Locked
Lake Street:
Locked
Locked
Sep 29 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Sep 29 2025
Locked
BTIG:
Locked
Locked
Sep 29 2025
Locked
BTIG:
Locked
Locked
Sep 24 2025
Locked
BTIG:
Locked
Locked
Sep 23 2025
Locked
Craig-Hallum:
Locked
Locked
Sep 23 2025
Locked
B. Riley Securities:
Locked
Locked
Sep 23 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today